Strategic Partnerships Next Breath operates as a contract services provider for pharmaceutical, biotech and medical device companies focusing on inhalation and nasal delivery. This positions them as a potential partner for firms seeking specialized preclinical formulation development and analytical testing support, especially in regulatory submissions.

Niche Expertise With in-vitro services spanning pre-clinical formulation development to analytical testing for regulatory submissions, Next Breath can upsell services to companies developing inhaled therapies, offering end-to-end support that accelerates time to market.

Mid-market Focus Headquartered in Baltimore with a small team (11-50 employees) and revenue in the 10–25 million range, Next Breath is well-positioned to engage mid-sized pharma, biotech, and device innovators seeking agile partners for specialized inhalation/nasal product development.

Technical Collaboration Recent collaboration activity with Gateway Analytical and Circassia highlights openness to joint presentations and technical partnerships. This suggests opportunities for co-development, shared IP exploration, and multi-party projects to drive faster regulatory approvals.

Growth Signals The combination of a clear focus on inhalation and nasal delivery, a track record of regulatory-support services, and a revenue scale that supports targeted expansion indicates potential for expanding client base through outreach to both small innovators and mid-sized product developers seeking specialized outsourcing.